drugset / Trial / NCT00523705

Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study

NCT00523705

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this pilot study is to determine the efficacy and safety of escitalopram administered premenstrually (day 14 through day 2 of the menstrual cycle) for severe PMS in young women ages 15-19 years.

Timeline

Start
2008-02
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg
Subject Escitalopram Small molecule 20 mg

Indications